Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma

被引：24
|
作者：
Schlottmann, Francisco [1 ,2 ]
Molena, Daniela [3 ]
Patti, Marco G. [1 ,4 ]
机构：
[1] Univ N Carolina, Dept Surg, 4030 Burnett Womack Bldg,101 Manning Dr,CB 7081, Chapel Hill, NC 27599 USA
[2] Univ Buenos Aires, Hosp Aleman Buenos Aires, Dept Surg, Buenos Aires, DF, Argentina
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[4] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA
来源：
UPDATES IN SURGERY | 2018年 / 70卷 / 03期
关键词：
Gastroesophageal reflux disease; Barrett's esophagus; Metaplasia; Low-grade dysplasia; High-grade dysplasia; Esophageal adenocarcinoma; RISK-FACTORS; NEOPLASTIC PROGRESSION; GRADE DYSPLASIA; METAANALYSIS; EXPRESSION; CANCER; METAPLASIA; EPITHELIUM; ACID; BILE;
D O I：
10.1007/s13304-018-0564-y
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The incidence of esophageal adenocarcinoma (EAC) has increased significantly in Western countries. The rising prevalence of gastroesophageal reflux disease (GERD) and obesity has played a major role in the increasing numbers of EAC. Approximately 10-15% of patients with GERD will develop Barrett's esophagus (BE). This metaplastic transformation is due to the chronic injury produced by repeated reflux episodes and involves genetic mutations that can lead to a malignant transformation. Ultimately, the development of EAC is characterized by the sequence BE metaplasia-dysplasia-invasive carcinoma.
引用
收藏
页码：339 / 342
页数：4
相关论文
共 50 条
  • [31] Prevention of Barrett Esophagus and Esophageal Adenocarcinoma by Smoothened Inhibitor in a Rat Model of Gastroesophageal Reflux Disease
    Gibson, Michael K.
    Zaidi, Ali H.
    Davison, Jon M.
    Sanz, Alejandro F.
    Hough, Bruce
    Komatsu, Yoshihiro
    Kosovec, Juliann E.
    Bhatt, Astha
    Malhotra, Usha
    Foxwell, Tyler
    Rotoloni, Christina L.
    Hoppo, Toshitaka
    Jobe, Blair A.
    [J]. ANNALS OF SURGERY, 2013, 258 (01) : 82 - 88
  • [32] Gastroesophageal reflux, Barrett esophagus, and esophageal cancer - Clinical applications
    Shaheen, N
    Ransohoff, DF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15): : 1982 - 1986
  • [33] Gastroesophageal reflux, Barrett esophagus, and esophageal cancer - Scientific review
    Shaheen, N
    Ransohoff, DF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15): : 1972 - 1981
  • [34] Reflux, Barrett's, and Adenocarcinoma of the Esophagus: Can We Disrupt the Pathway?
    DeMeester, Steven R.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (06) : 941 - 945
  • [35] Reflux, Barrett’s, and Adenocarcinoma of the Esophagus: Can We Disrupt the Pathway?
    Steven R. DeMeester
    [J]. Journal of Gastrointestinal Surgery, 2010, 14 : 941 - 945
  • [36] Barrett's esophagus and esophageal adenocarcinoma
    Sarisley, Christine
    [J]. GASTROENTEROLOGY NURSING, 2008, 31 (01) : 76 - 77
  • [37] Barrett's Esophagus and Esophageal Adenocarcinoma
    Bresalier, Robert S.
    [J]. ANNUAL REVIEW OF MEDICINE, 2009, 60 : 221 - 231
  • [38] Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction
    Chak, Amitabh
    Ochs-Balcom, Heather
    Falk, Gary
    Grady, William M.
    Kinnard, Margaret
    Willis, Joseph E.
    Elston, Robert
    Eng, Charis
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (09) : 1668 - 1673
  • [39] Barrett's Esophagus and esophageal Adenocarcinoma
    Bloemer, M.
    Jaehne, J.
    [J]. CHIRURG, 2013, 84 (03): : 232 - 232
  • [40] Effect of Helicobacter pylori Infection on Barrett's Esophagus and Esophageal Adenocarcinoma Formation in a Rat Model of Chronic Gastroesophageal Reflux
    Liu, Fang-Xun
    Wang, Wei-Hong
    Wang, Jing
    Li, Jiang
    Gao, Pei-Pei
    [J]. HELICOBACTER, 2011, 16 (01) : 66 - 77
12345